Yahoo
NSE - Delayed Quote INR

Niva Bupa Health Insurance Company Limited (NIVABUPA.NS)

74.10 +1.45 (+2.00%)
At close: 3:30:02 PM GMT+5:30
NIVABUPA.NS Q2 2027 earnings call
November 4, 2026 at 5 PM GMT+5:30
Chart Range Bar
Loading chart for NIVABUPA.NS
  • Previous Close 72.65
  • Open 72.70
  • Bid --
  • Ask --
  • Day's Range 72.66 - 74.69
  • 52 Week Range 67.50 - 91.40
  • Volume 488,932
  • Avg. Volume 1,258,198
  • Market Cap (intraday) 137.059B
  • Beta (5Y Monthly) --
  • PE Ratio (TTM) 38.00
  • EPS (TTM) 1.95
  • Earnings Date --
  • Forward Dividend & Yield -- (0.00%)
  • Ex-Dividend Date --
  • 1y Target Est 99.09

Niva Bupa Health Insurance Company Limited provides health insurance products in India. It offers health insurance plans, such as individual, family, NRIs, senior citizens, personal accident, critical illness, disease-specific, hospital cash, and maternity insurance; travel insurance plans, including international and studying abroad insurance; and corporate insurance plans comprising group and start up health, group personal accident, and OPD coverage, as well as group health insurance claim process. The company was formerly known as Max Bupa Health Insurance Company Limited and changed its name to Niva Bupa Health Insurance Company Limited in July 2021. The company was incorporated in 2008 and is based in Gurugram, India. Niva Bupa Health Insurance Company Limited operates as a subsidiary of Bupa Singapore Holdings Pte. Ltd.

www.nivabupa.com

--

Full Time Employees

March 31

Fiscal Year Ends

Insurance - Life

Industry

Recent News

View More

Performance Overview

Trailing total returns as of 11/2/2026, which may include dividends or other distributions. Benchmark is S&P BSE SENSEX (^BSESN) .

YTD Return

NIVABUPA.NS
1.72%
S&P BSE SENSEX (^BSESN)
11.18%

1-Year Return

NIVABUPA.NS
1.28%
S&P BSE SENSEX (^BSESN)
9.82%

3-Year Return

NIVABUPA.NS
5.17%
S&P BSE SENSEX (^BSESN)
18.12%

5-Year Return

NIVABUPA.NS
5.17%
S&P BSE SENSEX (^BSESN)
26.09%

Earnings Trends

View More

Earnings Per Share (Normalized)

Revenue vs. Earnings

Annual
Quarterly
Annual
Quarterly
Q1 FY27
Revenue 22.74B
Earnings 1.38B
Profit Margin 6.06%

Q2

FY26

Q3

FY26

Q4

FY26

Q1

FY27

0
5B
10B
15B
20B
-5.0%
0.0%
5.0%
10.0%
15.0%

Analyst Insights

View More

Analyst Price Targets

90.00
99.09 Average
74.10 Current
105.00 High

Analyst Recommendations

  • Strong Buy
  • Buy
  • Hold
  • Underperform
  • Sell

Statistics

View More

Valuation Measures

Annual
  • Market Cap

  • Enterprise Value

  • Trailing P/E

  • Forward P/E

  • PEG Ratio (current)

  • Price/Sales (ttm)

  • Price/Book (mrq)

  • Enterprise Value/Revenue

  • Enterprise Value/EBITDA

Financial Highlights

Profitability and Income Statement

  • Profit Margin

    4.81%

  • Return on Assets (ttm)

    --

  • Return on Equity (ttm)

    12.14%

  • Revenue (ttm)

    89.83B

  • Net Income Avi to Common (ttm)

    4.33B

  • Diluted EPS (ttm)

    1.95

Balance Sheet and Cash Flow

  • Total Cash (mrq)

    784M

  • Total Debt/Equity (mrq)

    6.80%

  • Levered Free Cash Flow (ttm)

    --

Company Insights

Research Reports

View More

People Also Watch

Mobilize your Website
View Site in Mobile | Classic
Share by: